Last reviewed · How we verify

NCT07360457

GLP1 Analogues and the Risk of Osteoarthritis

Not yet recruiting Last updated 22 January 2026
What this trial tests

trial testing GLP-1 analog in Osteoarthritis in 390 participants. Not yet recruiting.

Timeline
1 February 2026
Primary endpoint
1 December 2026
1 March 2027

Quick facts

Lead sponsorBeni-Suef University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment390
Start date1 February 2026
Primary completion1 December 2026
Estimated completion1 March 2027

Drugs / interventions tested

Conditions studied

Sponsor

Beni-Suef University

Who can join

50 and older, any sex, with Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assessing the effects of GLP1 RA Vs SGLT2 Inhibitors vs. Standard of care in joint pain, physical function, stiffness, and improving Quality of Life for patients with type 2 diabetes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Osteoarthritis

Currently open trials in the same condition.

Other Beni-Suef University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07360457.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing